NonExomics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Based in Beverly, Massachusetts, the firm maintains a small, highly specialized team and seeks collaborations with researchers and biopharma partners exploring novel drug targets beyond conventional biology. Its target portfolio represents an expansive, underexplored area in drug discovery that could be pursued with a range of therapeutic modalities. In 2022, NonExomics announced the launch of a technology platform aimed at illuminating these targets and entered into a research agreement with Ordaos Bio to develop customized mini-proteins for difficult-to-treat rare cancers.